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      BSTRACT
In this case series, the occurrence and successful treatment of anaphylaxis after the intra-
venous administration of amoxicillin/clavulanic acid are described in two dogs under general 
anesthesia. Within five to ten minutes after the administration of the antibiotic, a severe hypo-
tension occurred in both dogs, accompanied by labial and periorbital swelling and erythema. 
Therapy consisted of counteracting the cardiovascular effects of anaphylaxis and preventing 
further release of inflammatory mediators. Both dogs recovered uneventfully from the drug-
related anaphylaxis.
SAMENVATTING
Deze casuïstiek handelt over het ontstaan en de succesvolle behandeling van anafylactische shock 
na de intraveneuze toediening van een amoxicilline/clavulaanzuurpreparaat bij twee honden onder 
algemene anesthesie. Binnen de vijf tot tien minuten na de toediening van het antibioticum trad bij 
beide honden een ernstige bloeddrukdaling op. Tevens werd een labiale en periorbitale zwelling met 
erytheem waargenomen. De therapie bestond uit de behandeling van de negatieve cardiovasculaire 
effecten van de anafylactische shock en het verhinderen van een verdere vrijstelling van ontstekings-
mediatoren. Bij beide honden was de therapie succesvol.
A
INTRODUCTION
Amoxicillin/clavulanic acid is an extended spec-
trum penicillin that is effective against most gram-
positive, some gram-negative and anaerobic bacteria, 
and therefore has multiple therapeutic indications 
(Unterer et al., 2011). In Belgium, the drug is regis-
tered for use in dogs as a formulation for oral and sub-
cutaneous administration. However, for perioperative 
antibiotic prophylaxis, the intravenous (IV) adminis-
tration of antibiotics is usually preferred above other 
routes of administration, especially if there is a septic 
risk profile, since therapeutic plasma concentrations 
are reached more rapidly (Boothe, 2001). Since there 
is no registered amoxicillin/clavulanic acid prepara-
tion for IV administration in dogs, a preparation 
registered for humans can be used. However, timely 
administration of an antibiotic preparation registered 
for subcutaneous administration in dogs is a good 
alternative to achieve adequate plasma concentrations 
during elective surgery.   
Like any other drug, the administration of anti-
biotics carries the risk of anaphylactic reactions. In 
human medicine, intravenous antibiotics are responsi-
ble for most of the reported drug-related anaphylactic 
reactions, followed by non-steroidal anti-inflamma-
tory drugs (NSAIDs), antineoplastic/cytotoxic drugs, 
immune modulators, vaccines and radiographic con-
trast agents (Van der Klauw et al., 1993; Lee and 
Shanson, 2007; Klimek et al., 2012; Ribeiro-Vaz et 
al., 2013). A recent human retrospective study showed 
that as much as 49.6% of the reported anaphylaxis 
cases (of a total of 333 cases) were caused by antibio-
tics, and that amoxicillin was involved in nearly one 
third of the cases (Renaudin et al., 2013). Although 
the veterinary literature reports on anaphylaxis caused 
by the same drugs as described in human medicine 
(Shmuel and Cortes, 2013), the authors did not find 
any case report on anaphylaxis following IV amoxi-
cillin/clavulanic acid administration in dogs.
This case series presents two cases of apparent 
anaphylaxis after the IV administration of amoxicil-
lin/clavulanic acid (Augmentin®P 500 mg/50 mg; 
GlaxoSmithKline, Italy) at a dose of 20 mg/kg during 
inhalation anesthesia in dogs.
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CASE PRESENTATIONS
Case 1
A 2.5-year-old, male English bulldog weighing 
29 kg was hit by a car. At admittance to the Depart-
ment of Medicine and Clinical Biology of Small 
Animals of the Faculty of Veterinary Medicine 
(Ghent University), a large rectangular skin abrasion 
(50 x 6 cm) was present at the right lateral thorax. 
Additionally, a neurological diagnosis of brainstem 
or cervical trauma (C1-C5) was made, based on the 
presence of mild ataxia and a hypermetric gait on 
the front legs. The dog was kept in observation for 
the neurological symptoms, analgesic treatment and 
treatment of the skin abrasion, which included oral 
amoxicillin/clavulanic acid (Clavubactin 500 mg/125 
mg; Le Vet, the Netherlands) 12.5 mg/kg q 12 h PO 
(from day 4 onwards, when the lesion had become 
necrotic). On day 6, the dog was scheduled for sur-
gical correction of the skin wound. Pre-anesthetic 
evaluation and blood work revealed no abnormali-
ties, and the dog was considered to be an ‘American 
Society of Anesthesiologists (ASA) grade II patient’ 
(mild systemic disease, no incapacity). A 20-gauge 
catheter was aseptically placed in a cephalic vein. 
Premedication consisted of methadone 0.2 mg/kg 
(Mephenon; Denolin, Belgium) IV, and the degree 
of sedation was considered sufficient. Fifteen min-
utes later, anesthesia was induced with propofol 3.5 
mg/kg (Propovet; Abbott Animal Health, UK) IV. 
Subsequently, a 7-mm internal diameter cuffed endo-
tracheal tube was placed, and anesthesia was further 
maintained with isoflurane (Isoflo; Abbott Animal 
Health, UK) vaporized in oxygen using a rebreathing 
system with a fresh gas flow of 1 L/minute. A lactated 
Ringer’s solution (Hartmann; Baxter, Belgium) was 
infused IV at 10 mL/kg/hour throughout anesthesia. 
Following the induction of anesthesia, carprofen 2 
mg/kg (Rimadyl; Pfizer Animal Health, Belgium) 
was administered IV. The dog was allowed to breathe 
spontaneously during the preparation for surgery, but 
was mechanically ventilated during the surgical pro-
cedure. During anesthesia, the respiratory rate, heart 
rate (HR), arterial oxygen saturation, systolic (SAP), 
diastolic (DAP) and the mean arterial (MAP) blood 
pressures (indirect oscillometric method, median 
artery, midradial region), inspired oxygen percent-
age (FiO2), inspired isoflurane percentage, end-tidal 
isoflurane percentage (Fe´ISO) and end-tidal partial 
pressure of CO2 were measured continuously (Cicero; 
Dräger, Germany), and recorded every 10 minutes. 
A three-lead electrocardiogram was attached (Datex 
Cardiocap; Datex-Ohmeda, Finland). The patient was 
positioned on a circulating hot water mattress (Gay-
mar TP500; Gaymar Industries Inc., USA). 
During the first 20 minutes of anesthesia, all 
measured parameters were stable and within their 
respective physiological reference values. After 25 
minutes into the anesthetic period (before the start of 
surgery), amoxicillin/clavulanic acid 20 mg/kg was 
administered slowly IV. Within 5 minutes following 
this injection, a dramatically low SAP (60 mm Hg) 
was observed, together with labial and periorbital 
swelling and erythema. At this time point, the oscillo-
metric blood pressure monitor was not able to display 
a value for DAP and MAP. The heart rate was 140 
beats/minute, which was not higher than the previous 
measurements. Ephedrine 0.1 mg/kg (Efedrine HCl; 
Denolin, Belgium) was administered twice IV with 
a 5-minute interval to treat the hypotension, but the 
restoration of the normal blood pressure only lasted 
for a short period (5-10 minutes). At the time of the 
second ephedrine administration, promethazine 0.4 
mg/kg (Phenergan; Haupt Pharma Livron, France) 
was administered intramuscularly (IM). A continuous 
rate infusion (CRI) of noradrenaline 0.7 µg/kg/minute 
(Levophed; Hospira SPA, Italy) was started. This 
treatment was able to keep the blood pressure within 
normal values continuously. The noradrenaline CRI 
was reduced to 0.5 µg/kg/minute after 10 minutes, 
further reduced to 0.3 µg/kg/minute 20 minutes later 
and stopped 90 minutes after the onset of the suspected 
anaphylactic reaction. Additionally, the Fe´ISO was 
decreased from 1.4% to 0.9% immediately following 
the onset of the suspected anaphylactic event. At that 
time, a CRI of fentanyl (Fentanyl; Janssen Pharma-
ceutica, Belgium) of 5 µg/kg/hour was started and 
intermittent positive pressure ventilation was initiated 
and maintained throughout anesthesia. At the time of 
the discontinuation of norepinephrine CRI (90 minutes 
after the onset of the suspected anaphylactic shock), 
the facial swelling and erythema had disappeared and 
the normal blood pressure was maintained without 
further treatment during the remaining anesthetic 
period (another 40 minutes). The surgical resection of 
necrotic skin tissue and the closure of the wound were 
successful, and the dog’s recovery was uneventful. 
The total anesthesia time was 160 minutes. The post-
operative treatment consisted of methadone 0.2 mg/kg 
IV q 4 hours for 24 hours, oral amoxicillin/clavulanic 
acid for 5 days and oral carprofen 2 mg/kg q 12 h as 
well as the topical application of a silversulphadiazine 
ointment (Flammazine; Recipharm Parets SL, Spain) 
on the wound 4 times a day. The dog was discharged 
from the hospital 2 days after the event.
Case 2
A 5.3-year-old, female, spayed Sheltie weighing 
20 kg, was admitted for emergency surgery to the 
Department of Medicine and Clinical Biology of 
Small Animals of the Faculty of Veterinary Medicine 
(Ghent University) with acute bile peritonitis due to 
rupture of a bile bladder mucocoele. The dog had 
already received oral amoxicillin/clavulanic acid 12.5 
mg/kg q 12 h PO for 3 weeks, and was concurrently 
treated for hypothyroidism with levothyroxine (For-
thyron; Eurovet, Belgium) 0.01 mg/kg q 12 hours PO 
and for allergic dermatitis with methylprednisolon 
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(Moderin; Pfizer Animal Health, Belgium) 48 mg PO 
every 2 days. On pre-anesthetic evaluation, the dog 
had a HR of 176 beats/minute, a prolonged capillary 
refill time, tacky mucosae and weak femoral pulses. 
A 20-gauge catheter was placed aseptically in both 
cephalic veins. Pre-anesthetic blood work revealed 
neutrophilia (31.16 109), anemia (hematocrit: 24.5%), 
hypoalbuminemia (15 g/L), hypoproteinemia (total 
protein: 39 g/L), increased alkaline phosphatase (317 
U/L), decreased urea (1.9 mmol/L) and decreased 
creatinine (25 µmol/L). The dog was considered an 
‘ASA IV-E grade patient’ (extreme systemic disease 
constituting a threat to life; E = emergency). Prior 
to anesthesia, the hypovolemic shock was stabilized 
with 3 IV boluses of Lactated Ringer’s solution (20 
mL/kg each, administered over 10 minutes) and a 
bolus of hydroxyethylstarch 6% 10 mL/kg (Tetraspan 
6%; B Braun Melsungen AG, Germany).
Premedication consisted of methadone 0.2 mg/kg 
(Comfortan; Dechra, Belgium) IV. Twenty minutes 
later, anesthesia was induced IV with fentanyl 5 µg/kg 
followed by midazolam 0.5 mg/kg (Dormicum; Roche 
NV, Belgium) and alfaxalone 0.25 mg/kg (Alfaxan; 
Vétoquinol, Belgium). Subsequently, a 7-mm internal 
diameter cuffed endotracheal tube was placed, and 
anesthesia was further maintained with isoflurane 
(Isoflo; Abbott Animal Health, UK) vaporized in oxy-
gen/air (FiO2 = 65%) using a rebreathing system with 
a fresh gas flow of 2 L/minute. Lactated Ringer’s solu-
tion (Hartmann; Baxter, Belgium) was infused IV at 10 
mL/kg/hour throughout anesthesia, as was fresh frozen 
plasma (25 mL/hour for the first half hour, followed by 
50 mL/hour; total dose = 10 mL/kg). A fentanyl CRI of 
5 µg/kg/hour was infused throughout anesthesia. Dur-
ing anesthesia, the same vital parameters as in case 1 
were monitored continuously, using similar equipment 
and recorded at a 10-minute interval.
Ten minutes following the induction of anesthesia, 
amoxicillin/clavulanic acid 20 mg/kg was adminis-
tered slowly IV over 10 minutes. Within 10 minutes 
following the end of the administration, the arterial 
blood pressure dropped from 131/46 (73) [SAP/DAP 
(MAP)] pre-anaphylaxis to 48/17 (33), and a severe 
cutaneous reaction (facial and periorbital swelling 
with erythema) was observed. Ephedrine 0.1 mg/kg 
was first administered IV and was repeated together 
with promethazine 0.3 mg/kg IM after 5 minutes. 
A bolus of hydroxyethylstarch 6% of 5 mL/kg was 
administered 10 minutes later. Ranitidine was subse-
quently administered IM at a dose of 2 mg/kg. The 
blood pressure remained  low 68/34 (49) [SAP/DAP 
(MAP)] and a CRI of noradrenaline of 0.2 µg/kg/
minute was started, which was increased to 0.4 µg/kg/
minute after 30 minutes. This dose restored the blood 
pressure to acceptable levels [the lowest measured 
blood pressure was 88/36 (64)]. The noradrenaline 
CRI was continued until the end of anesthesia (140 
minutes). Skin reactions resolved during anesthesia. 
The total anesthesia time was 200 minutes. The 
recovery from anesthesia was slow and the dog was 
initially hypothermic (rectal temperature: 33.6 °C). 
A heated air mattress (3MTMBair-HuggerTM; Arizant 
Healthcare inc., USA) was used to increase the body 
temperature. The postoperative blood pressure (Dop-
pler method, digital palmar artery) was stable (SAP 
between 95-130 mm Hg) without treatment. The 
urinary production was sufficient. The postoperative 
analgesia consisted of methadone 0.2 mg/kg and ket-
amine 1 mg/kg IV q 4 hours for the first 24 hours. Five 
hours postoperatively, a bolus of lidocaine 2 mg/kg 
(Xylocaine 2%; AstraZeneca, Belgium) was admin-
istered, followed by a CRI of lidocaine of 30 µg/
kg/minute. The antibiotics consisted of enrofloxacin 
(Baytril 2.5%; Bayer Animal Health, Belgium) 5 mg/
kg IV q 24h and cefazoline (Cefazoline 1g; Sandoz, 
Austria) 20 mg/kg IV q 8h. Over the next two days 
however, the dog’s condition worsened as a result of 
the primary disease and she died on the third day after 
surgery.
DISCUSSION
Anaphylaxis is a severe, potentially fatal, systemic 
allergic reaction that occurs suddenly after contact 
with an allergy causing substance (Sampson et al., 
2006). In 2005, the clinical characteristics for the 
diagnosis of anaphylaxis were delineated by a panel 
recruited by the National Institutes of Health and the 
Food Allergy and Asthma Network (Shmuel and Cor-
tes, 2013). Anaphylaxis is considered highly likely 
when there is an acute onset of illness (minutes to 
several hours) after the administration of a possible 
allergen, with involvement of the skin, mucosal tissue 
or both in combination with a reduced blood pressure 
(Sampson et al., 2005; Sampson et al., 2006). The 
speed of the onset of the observed symptoms (within 
10 minutes after the IV administration of amoxicil-
lin/clavulanic acid) in both described cases, together 
with the organ distribution of the symptoms (skin and 
cardiovascular system) therefore strongly support the 
diagnosis of anaphylaxis related to the administration 
of amoxicillin/clavulanic acid.
Since the anaphylactic events occurred quickly 
after the administration of amoxicillin/clavulanic 
acid, this drug most likely caused the anaphylactic 
reactions. However, other perioperatively adminis-
tered drugs, such as opioids and NSAIDs, are also 
commonly identified as allergens in the veterinary 
literature (Shmuel et al., 2013). It is therefore dif-
ficult to definitely exclude their involvement in the 
observed anaphylaxis. The administration of fresh 
frozen plasma in case 2 was started after the occur-
rence of anaphylaxis, and could thus not have caused 
the event. Besides resulting from anaphylaxis, a drop 
in blood pressure and a subsequent rise in HR may 
also result from an increased depth of anesthesia or 
hypovolemia. However, no signs of increased anes-
thetic depth were present at the time of the anaphy-
lactic events. The pre-existing hypovolemia in case 2 
was corrected preoperatively, and the initial blood 
Vlaams Diergeneeskundig Tijdschrift, 2014, 83 17
pressure measurements during anesthesia were within 
reference ranges. Additionally, the observed facial 
swelling and erythema are typical symptoms associ-
ated with histamine release during anaphylaxis, and 
cannot be explained as a consequence of anesthesia 
(Girard and Leece, 2010). 
Anaphylaxis can be classified as immunologic 
and nonimmunologic anaphylaxis (Simons et al. 
2011). Immunologic anaphylaxis is subdivided in 
immunologic immunoglobin E (IgE)-mediated and 
non-IgE mediated anaphylaxis. The former involves 
a true immune-mediated response at which during the 
first exposure to a drug, IgE antibodies are produced, 
which bind to specific receptors on mast cells and 
basophil membranes. Following the second exposure 
to the same drug or when there is cross-reactivity at 
IgE-receptors with other drugs or chemicals (at the 
first exposure to a drug), the binding of the antigen 
to these receptors results in receptor activation and 
ultimately results in histamine, prostaglandin and 
leukotrienes release (Armitage-Chan, 2010; Simons 
et al., 2011). These mediators evoke a variety of 
symptoms associated with anaphylaxis (edema, ery-
thema, pruritus of the skin; hypotension, tachycardia, 
syncope, cardiovascular collapse, increased vessel 
permeability; bronchoconstriction; diarrhea, vomit-
ing) (Armitage-Chan, 2010; Girard and Leece, 2010; 
Ribeiro-Vaz et al., 2013). Beta-lactam antibiotics, 
such as amoxicillin/clavulanic acid, commonly cause 
immunologic IgE-mediated anaphylaxis (Antunez et 
al., 2006; Simons et al., 2011; Ansari et al., 2012). 
The immunologic non-IgE mediated anaphylaxis 
is caused by immune aggregates, complement or 
coagulation system activation and autoimmune 
mechanisms (Simons et al., 2011). In nonimmuno-
logic anaphylactic reactions (also classified as ana-
phylactoid reactions), the observed symptoms are a 
result of the direct release of mast cell and basophil 
mediators, and may thus appear at the first expo-
sure to a drug (Johansson et al., 2004; Descotes et 
al., 2007; Armitage-Chan, 2010; Girard and Leece, 
2010). Chemotherapeutic drugs, contrast agents, 
vancomycin, NSAIDs, local anesthetics and opiates 
commonly cause nonimmunologic drug reactions 
(Farnam et al., 2012). 
A true differentiation between immunologic IgE-
mediated and the other forms of anaphylaxis is only 
possible following in vitro specific IgE tests, an oral 
challenge or bronchoprovocation test or skin testing for 
selected substances (Farnam et al., 2012). Since none 
of these tests were performed in the present cases, it is 
impossible to definitely classify the observed adverse 
reactions. However, an IgE-mediated anaphylaxis 
seems most likely, since beta-lactam antibiotics are 
known to cause IgE-mediated anaphylaxis, and prior 
administration of the antibiotic might have resulted 
in IgE-antibody production (both dogs received oral 
amoxicillin/clavulanic acid before anesthesia). Non-
IgE mediated anaphylaxis due to cross-reactivity of 
another chemical comprised in the chemical prepara-
tion of the amoxicillin/clavulanic acid preparation is 
impossible, since the used preparation is free of any 
excipient. However, true IgE mediated anaphylaxis 
can be suspected to result in the reoccurrence of ana-
phylaxis when the inflicting drug is readministered, 
regardless of the route of administration. In case 1, the 
amoxicillin/clavulanic acid treatment was continued 
PO in the postoperative period; however, without reoc-
currence of anaphylaxis. Park et al. (1992) stated that 
the route of administration of antigens is important in 
determining the type of generated allergic response, 
with the parenteral route being most sensitizing for 
the development of IgE-mediated anaphylaxis. Since 
intravenous infusion of an allergen is associated with 
the risk of more severe reactions, the risk of fatal ana-
phylaxis is also greater in patients receiving parenteral 
amoxicillin or penicillin than in patients receiving oral 
administration (Park and Kitteringham, 1992, Brazil-
ian Association of Allergy and Immunopathology and 
Brazilian Society of Anesthesiology, 2013; Renaudin 
et al., 2013; Shmuel et al., 2013). Therefore, it might 
be that the antigen challenge after oral administra-
tion in the postoperative period was not able to elicit 
reactions in the dog of case 1. At the Department of 
Medicine and Clinical Biology of Small Animals of 
the Faculty of Veterinary Medicine (UGent) and at 
other facilities, the authors know of several, less well-
documented cases of dogs suffering from an allergic 
reaction resulting from the IV administration of the 
same amoxicillin/clavulanic acid preparation, in both 
awake and anesthetized dogs. However, the authors 
have never observed any anaphylactic reaction dur-
ing oral treatment. Regardless of these findings, the 
authors believe that the continuation of amoxicillin/
clavulanic acid and other beta-lactam antibiotics by 
any route of administration after suspected anaphy-
laxis related to the administration of these drugs 
should be avoided. 
The treatment of anaphylaxis is a medical emer-
gency and is based on three phases. The first phase 
focuses on the withdrawal of the patient from the 
causative allergen, whenever possible. In the second 
phase, the clinical effects of anaphylaxis are coun-
teracted. These include airway management, oxygen 
supplementation, fluid therapy, discontinuation of 
anesthesia and immediate medical therapy (Girard and 
Leece, 2010). Epinephrine is considered the drug of 
choice in anaphylactic shock, and can best be admin-
istered in dogs as an IV CRI of 0.05 µg/kg/minute 
(Mink et al., 2004; Sampson et al., 2006; Girard and 
Leece, 2010; Simons and Simons, 2010). Epinephrine 
activates both α and β-receptors, resulting in increased 
systemic vascular resistance and a subsequent increase 
in blood pressure (α1-receptor activation), an increase 
in cardiac output, myocardial oxygen consumption, 
coronary artery dilatation (β1-receptor stimulation), 
bronchodilation, decreased peripheral vascular resis-
tance, decreased release of inflammatory mediators 
from mast cells and basophils and relief of urticaria 
(β2-receptor stimulation) (Peck et al., 2008a; Simons 
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et al., 2011). However, the different effects are dose-
dependent, with β-effects predominating at low doses 
and α-effects predominating at high doses (Peck et 
al., 2008a; Shmuel and Cortes, 2013). The third phase 
of anaphylaxis therapy consists of the prevention of 
further release of anaphylactic mediators by means of 
ancillary treatments, and includes the use of gluco-
corticoids, antihistaminics (ranitidine/cimetidine) and 
bronchodilators (Girard and Leece, 2010; Shmuel and 
Cortes, 2013). These additional treatments should be 
patient-based and tailored to the type and severity of 
the clinical signs.
The animals in the present cases were treated 
by different anesthetists. Anaphylaxis occurred 
during anesthesia. Therefore, the treatment was 
somewhat different from the guidelines above, and 
was approached as an anesthesia complication with 
hypotension as primary problem. Anesthesia might 
exacerbate the hypotension induced by anaphylaxis. 
Ansari et al. (2012) therefore highlight the impor-
tance of the administration of antibiotics and non-
anesthetic agents 30 minutes before the induction of 
anesthesia rather than along with anesthetic agents, 
to prevent the onset of anaphylaxis during anesthesia. 
Strict adherence to this protocol might help avoid 
morbidity. In the described cases, the animals’ vital 
parameters had already been well-monitored at the 
time of the onset of anaphylaxis, fluid therapy had 
already been installed, there was a patent secured 
airway and oxygen delivery was ongoing. In case 1, 
ideally, anesthesia should have been discontinued, 
whereas in case 2, this was no option since surgery 
was life-saving. In case 1, IV ephedrine and nor-
epinephrine and IM promethazine were selected as 
medication treatment. In case 2, a combination of IV 
plasma-expander administration, IV ephedrine and 
norepinephrine, IM promethazine and IV ranitidine 
was chosen. Ephedrine and norepinephrine were used 
as an alternative to epinephrine in the present cases. 
Ephedrine is an “inoconstrictor” (β1- and α-receptor 
effect) that increases the cardiac output, heart rate, 
blood pressure, coronary blood flow and myocardial 
oxygen consumption. It also causes bronchodilation 
(Peck et al., 2008a). Systemically infused norepine-
phrine causes vasoconstriction and a subsequent rise 
in blood pressure, but causes cardiac output to fall 
(Peck et al., 2008a). Promethazine is a phenothiazine 
with strong antihistamine effects and significant anti-
cholinergic properties (Peck et al., 2008b). The blood 
pressure was successfully restored in both patients, 
and the skin reactions were transient following the 
respective treatments. The dogs recovered from the 
anaphylactic episode within 90 and 140 minutes, 
respectively for cases 1 and 2.
In conclusion, the intravenous administration of 
a specific amoxicillin/clavulanic acid  preparation 
caused anaphylaxis in two dogs during anesthesia. 
Therapy focusing on the counteraction of the cardio-
vascular effects of anaphylaxis and the prevention of 
further release of anaphylactic mediators was suc-
cessful in reversing the anaphylactic reactions.
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DE LINTWORM
“Zijn lichaam is plat als een lint, tot vijf zes meters lang, zijne leden gelidwijze of articulatim, 
zoo de Latijnen zeggen, afgedeeld. Ieder lid – en daar zijn er machtig vele – is bekwaam om op zijn 
eigen eieren voort te brengen, al zate er maar een lintworm gansch alleen in het lijf. Die eieren laat 
de worm uit de menige eiranden en door den eierweg, waarvan ieder lid voorzien is, uitewaarts gaan. 
Het hoofd van den lintworm staat boven op het smalste ende van zijn  lijf. Het is vierkante en voorzien 
op de vier hoeken van vier zuigers, gelijk aan de zuigers waarmee de vliegenpooten zich aan de ruiten 
vast houden. De mondopeninge staat boven op den kop en is omringd door een wielken alderfijnste 
klouwkens, die overhands open- en toe gaan. Met dien mond en die klouwen weet de lintworm zijnen 
nooddruft te zichten (voedsel te zeven) en te zuigen uit de verteerde menschen spijze, terwijl zij staat 
om levend bloed te veranderen. De lintworm en verteert niet noch laat eenig overblijfsel van spijze 
uitewaarts zijn lichaam gaan. De mensch bij wien hij wonachtig is, doet dat al voor hem. Al dat de 
lintworm doet is eten, leven, eieren voort brengen, en ’t wordt bevestigt van hen die ’t weten dat een 
lintworm tot 10 miljoen eieren kan in hebben en meer, na de lengde zijns lijfs.”
Uit: Guido Gezelle’s “Uitstap in de Warande” (1865-1870 en 1882, 6de uitgave 1927, De Meester, 
Wetteren, 1927).
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